JP2013536235A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536235A5
JP2013536235A5 JP2013526084A JP2013526084A JP2013536235A5 JP 2013536235 A5 JP2013536235 A5 JP 2013536235A5 JP 2013526084 A JP2013526084 A JP 2013526084A JP 2013526084 A JP2013526084 A JP 2013526084A JP 2013536235 A5 JP2013536235 A5 JP 2013536235A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
groups
alkoxy
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013526084A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536235A (ja
JP5862669B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/048743 external-priority patent/WO2012027322A1/en
Publication of JP2013536235A publication Critical patent/JP2013536235A/ja
Publication of JP2013536235A5 publication Critical patent/JP2013536235A5/ja
Application granted granted Critical
Publication of JP5862669B2 publication Critical patent/JP5862669B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013526084A 2010-08-26 2011-08-23 ロイコトリエン産生のオキサジアゾール阻害剤 Active JP5862669B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37718110P 2010-08-26 2010-08-26
US61/377,181 2010-08-26
US201161511247P 2011-07-25 2011-07-25
US61/511,247 2011-07-25
PCT/US2011/048743 WO2012027322A1 (en) 2010-08-26 2011-08-23 Oxadiazole inhibitors of leukotriene production

Publications (3)

Publication Number Publication Date
JP2013536235A JP2013536235A (ja) 2013-09-19
JP2013536235A5 true JP2013536235A5 (https=) 2014-10-09
JP5862669B2 JP5862669B2 (ja) 2016-02-16

Family

ID=44533215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013526084A Active JP5862669B2 (ja) 2010-08-26 2011-08-23 ロイコトリエン産生のオキサジアゾール阻害剤

Country Status (4)

Country Link
US (1) US8580829B2 (https=)
EP (1) EP2609092B1 (https=)
JP (1) JP5862669B2 (https=)
WO (1) WO2012027322A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011292285A1 (en) 2010-08-16 2013-01-31 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
JP5862669B2 (ja) 2010-08-26 2016-02-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
JP5828188B2 (ja) * 2010-09-23 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
CA2812449A1 (en) * 2010-09-23 2012-03-29 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
WO2013116182A1 (en) * 2012-01-31 2013-08-08 Boehringer Ingelheim International Gmbh Heterocyclic compounds as inhibitors of leukotriene production
AR089853A1 (es) 2012-02-01 2014-09-24 Boehringer Ingelheim Int Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso
WO2014015054A1 (en) 2012-07-18 2014-01-23 Saint Louis University Beta amino acid derivatives as integrin antagonists
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
US9079866B2 (en) * 2013-02-04 2015-07-14 Janssen Pharmaceutica Nv Flap modulators
ES2670550T3 (es) 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Derivados de quinolina selectivamente sustituidos
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
JP6244036B2 (ja) * 2014-01-21 2017-12-06 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 呼吸器合胞体ウイルス感染症の処置および予防のためのイミダゾール
CN106414429B (zh) 2014-06-03 2020-01-03 爱杜西亚药品有限公司 吡唑化合物及其作为t型钙通道阻断剂的用途
SG11201805387RA (en) 2015-12-30 2018-07-30 Univ Saint Louis Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
MX388586B (es) 2016-12-16 2025-03-20 Idorsia Pharmaceuticals Ltd Combinacion farmaceutica que comprende un bloqueador del canal de calcio de tipo t.
CA3050348A1 (en) 2017-02-06 2018-08-09 Idorsia Pharmaceuticals Ltd A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
EP3661910B1 (en) * 2017-08-02 2023-08-16 Merck Sharp & Dohme LLC Novel substituted pyridine compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
WO2019027855A1 (en) * 2017-08-02 2019-02-07 Merck Sharp & Dohme Corp. NOVEL SUBSTITUTED PHENYL COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)
JP7805983B2 (ja) 2022-03-22 2026-01-26 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004740B1 (ru) 1999-08-06 2004-08-26 Янссен Фармацевтика Н.В. Интерлейкин-5 ингибирующие производные 6-азаурацила
US7319108B2 (en) 2004-01-25 2008-01-15 Sanofi-Aventis Deutschland Gmbh Aryl-substituted heterocycles, process for their preparation and their use as medicaments
US20070287736A1 (en) 2004-10-18 2007-12-13 Lin Chu Diphenyl Substituted Alkanes as Flap Inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
WO2007120574A2 (en) 2006-04-11 2007-10-25 Merck & Co., Inc. Diaryl substituted alkanes
US20080096900A1 (en) 2006-06-26 2008-04-24 Amgen Inc. Methods for treating atherosclerosis
ATE543810T1 (de) 2006-09-01 2012-02-15 Merck Sharp & Dohme Hemmer des 5-lipoxygenase aktivierenden proteins (flap)
WO2008128335A1 (en) 2007-04-20 2008-10-30 Merck Frosst Canada Ltd. Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
EP2170065A4 (en) 2007-06-20 2011-11-23 Merck Sharp & Dohme DIPHENYL SUBSTITUTED ALKANES
US20110003815A1 (en) 2007-10-10 2011-01-06 Merck & Co., Inc. Diphenyl substituted cycloalkanes
MX2011004570A (es) * 2008-10-31 2011-06-17 Merck Sharp & Dohme Antagonistas del receptor p2x3 para el tratamiento del dolor.
JP2012516885A (ja) 2009-02-04 2012-07-26 ファイザー・インク 4−アミノ−7,8−ジヒドロピリド[4,3−d]ピリミジン−5(6H)−オン誘導体
EP2568809A4 (en) 2010-05-12 2013-11-06 Univ Vanderbilt HETEROCYCLIC ALLOSTERE SULFON MGLUR4 POTENTIATORS, COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTIONS
AU2011292285A1 (en) * 2010-08-16 2013-01-31 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
JP5862669B2 (ja) 2010-08-26 2016-02-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
JP5828188B2 (ja) * 2010-09-23 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
CA2812449A1 (en) * 2010-09-23 2012-03-29 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production

Similar Documents

Publication Publication Date Title
JP2013536235A5 (https=)
JP2013545810A5 (https=)
JP2013534245A5 (https=)
CN110475775B (zh) 4-吡啶酮化合物或其盐、包含4-吡啶酮化合物的药物组合物及剂
AU2012313094B2 (en) Pyrazole carboxamides as janus kinase inhibitors
CA2903288C (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP7068295B2 (ja) B型肝炎ウイルス感染症の処置及び予防のための新規なテトラヒドロピリドピリミジン
JP2011525192A5 (https=)
JP2013537908A5 (https=)
JP2009263394A5 (https=)
JP2014506907A5 (https=)
JP2013510120A5 (https=)
JP2006508935A5 (https=)
EP2257539A1 (en) Substituted 4-hydroxypyrimidine-5-carboxamides
PH12015502114B1 (en) 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
JP2012529522A5 (https=)
JP2010506850A5 (https=)
JP2014507455A5 (https=)
JP2016505021A5 (https=)
JP2013512953A5 (https=)
JP2012097115A5 (https=)
JP2015504076A5 (https=)
JP2009543795A5 (https=)
JP2013540712A5 (https=)
EP3209296A1 (en) Ethyl n-boc piperidinyl pyrazolo pyridones as janus kinase inhibitors